Medicines, Fresenius, Genzyme, Boeing, Google, Puma: Intellectual Property - Bloomberg
Medicines Co. won a court ruling that may provide an additional four years of patent protection on its anticoagulant drug Angiomax, which accounts for almost all of the company’s revenue. U.S. District Judge